Difluoromethylornithine for the Treatment of Neuroblastoma in the Pediatric Population: Clinical Effectiveness, Cost-Effectiveness, and Guidelines


( Last Updated : October 5, 2018)
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA0971-000

Details


Question


  1. What is the clinical effectiveness of difluoromethylornithine (DFMO) for the treatment or preventative treatment of neuroblastoma in the pediatric population?

  2. What is the cost-effectiveness of difluoromethylornithine (DFMO) for the treatment or preventative treatment of neuroblastoma in the pediatric population?

  3. What are the evidence-based guidelines associated with the use of difluoromethylornithine (DFMO) for the treatment or preventative treatment of neuroblastoma in the pediatric population?


Key Message

One non-randomized study was identified regarding difluoromethylornithine (DFMO) for the treatment of prevention of neuroblastoma in the pediatric population.